Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$81.70
Seasonality Move:
10.86%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.29 | Buy |
| 20-day SMA: | 79.21 | Buy |
| 50-day SMA: | 83.11 | Sell |
| 200-day SMA: | 69.05 | Buy |
| 8-day EMA: | 79.37 | Buy |
| 20-day EMA: | 79.75 | Buy |
| 50-day EMA: | 81.05 | Buy |
| 200-day EMA: | 72.26 | Buy |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.06 | Sell |
| Relative Strength Index (14 RSI): | 52.7 | Buy |
| Chaikin Money Flow: | 3167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.49 - 84.37) | Buy |
| Bollinger Bands (100): | (77.45 - 85.49) | Buy |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 81.77 while BIB 8-day simple moving average is 78.29, which is a Buy signal.
-
The stock price of BIB is 81.77 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 79.21, which makes it a Buy.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 83.11 while BIB share price is 81.77, making it a Sell technically.
-
BIB stock price is 81.77 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 69.05, creating a Buy signal.
BIB Technical Analysis vs Fundamental Analysis
Buy
68
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a BuyThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $81.77. The Score for BIB is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
81.77
Share Volume:
3.2K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
90.91
52-Week Low:
33.78
Buy
68
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 81.77 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is not overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 81.77 while BIB 8-day exponential moving average is 79.37, which is a Buy signal.
-
The stock price of BIB is 81.77 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 79.75, which makes it a Buy.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 81.05 while BIB share price is 81.77, making it a Buy technically.
-
BIB stock price is 81.77 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 72.26, creating a Buy signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -1.06, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 52.7, which suggest ProShares Ultra Nasdaq Biotechnology is overbought
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (76.49 - 84.37), which suggest ProShares Ultra Nasdaq Biotechnology is a Buy
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (77.45 - 85.49), which suggest ProShares Ultra Nasdaq Biotechnology is a Buy
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.